Search research articles
Contact Us
Filters
Showing results (541-550 of 759) with videos related to
Page
of 76
Sort By:
Blood Cancer Journal
|
February 11, 2022
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, et al.
American Journal of Hematology
|
September 7, 2020
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
David C Fajgenbaum, David Wu, Aaron Goodman, et al.
Kidney International
|
November 12, 2021
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis
Samar M Said, Alejandro Best Rocha, Anthony M Valeri, et al.
American Journal of Hematology
|
January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Blood
|
August 16, 2017
Delineation of the timing of second-line therapy post-autologous stem cell transplant in patients with AL amyloidosis
Yi L Hwa, Rahma Warsame, Morie A Gertz, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology
|
July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
Francesca Gay, S Vincent Rajkumar, Morton Coleman, et al.
Mayo Clinic Proceedings
|
May 10, 2017
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
Taxiarchis V Kourelis, Robert A Kyle, David Dingli, et al.
American Journal of Hematology
|
June 25, 2016
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
Yi L Hwa, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
March 15, 2016
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
Taxiarchis V Kourelis, Francis K Buadi, Shaji K Kumar, et al.
Page
of 76
Search research articles
Search
Showing results (541-550 of 759) with videos related to
Sort By:
Page
of 76
Blood Cancer Journal
|
February 11, 2022
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, et al.
American Journal of Hematology
|
September 7, 2020
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
David C Fajgenbaum, David Wu, Aaron Goodman, et al.
Kidney International
|
November 12, 2021
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis
Samar M Said, Alejandro Best Rocha, Anthony M Valeri, et al.
American Journal of Hematology
|
January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Blood
|
August 16, 2017
Delineation of the timing of second-line therapy post-autologous stem cell transplant in patients with AL amyloidosis
Yi L Hwa, Rahma Warsame, Morie A Gertz, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology
|
July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
Francesca Gay, S Vincent Rajkumar, Morton Coleman, et al.
Mayo Clinic Proceedings
|
May 10, 2017
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
Taxiarchis V Kourelis, Robert A Kyle, David Dingli, et al.
American Journal of Hematology
|
June 25, 2016
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
Yi L Hwa, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
March 15, 2016
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
Taxiarchis V Kourelis, Francis K Buadi, Shaji K Kumar, et al.
Page
of 76